Quality of Anticoagulation Control in Preventing Adverse Events in Patients with Heart Failure in Sinus Rhythm: Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Trial Substudy

Circulation: Heart Failure

Volumn 8, Issue 3, 2015, Pages 504-509

  Homma, Shunichi ^a   Thompson, John L P ^b   Qian, Min ^b   Ye, Siqin ^a   Di Tullio, Marco R ^a   Lip, Gregory Y H ^c   Mann, Douglas L ^d   Sacco, Ralph L ^e   Levin, Bruce ^b   Pullicino, Patrick M ^a,f   Freudenberger, Ronald S ^g   Teerlink, John R ^h   Graham, Susan ⁱ   Mohr, J P ^a   Labovitz, Arthur J ^j   Buchsbaum, Richard ^b   Estol, Conrado J ^k   Lok, Dirk J ^l   Ponikowski, Piotr ^m   Anker, Stefan D ⁿ   Ammon, S ^o   Massie, B ^o   Moy, C ^o   Gilbert, P ^o   Gutmann, L ^o   Marler, J ^o   Mejia, V ^o   Gabriel, A ^o   Borden, S ^o   Pena E ^o   Harris, C ^o   Khadouri, R ^o   Gohs, D ^o   Brown, M ^o   Berry, G ^o   Disantis, D ^o   Scullin, M ^o   Smith, P ^o   Kohsaka, S ^o   Watson, W ^o   Guillory, L ^o   Del Valle, M ^o   Sanford, A ^o   Levy, G ^o   Tea, K ^o   Grier, J ^o   Swydan, L ^o   O'Hare, B ^o   Prodhan, R ^o   Arbing, R ^o   Flanagan, E ^o   Duverger, E ^o   Peljto, A ^o   Lo, W ^o   Tierney, A ^o   Henriquez, A ^o   del Zoppo, G J ^o   Albers, G W ^o   Eliasziw, M ^o   Hinchey, J A ^o   Johnston, K C ^o   Swain, J A ^o   Slomiak, S ^o   Cape, L ^o   Barnett, H J ^o   Bruno, A ^o   Easton, J D ^o   Levine, S ^o   Sahlas, D ^o   Bleyer, F ^o   Carson, P ^o   Ellis, A ^o   Miller, A ^o   Bierig, M ^o   Liu, R ^o   Donato, C ^o   Hart, R ^o   McKay, C ^o   Wilson, L ^o   Frey, E ^o   Hayward, K ^o   Stein Beal, P ^o   Konczarek, L ^o   Diek, M ^o   Rohwedder, M ^o   Bohdanowicz Zazula, M ^o   Peerenboom Fey, C F ^o   Vissiennon, M ^o   Rex, G ^o   Varga, M ^o   Kovtun, O ^o   Orlyk, V ^o   Arenberger, P ^o   Jaros, J ^o   Ruiz, A ^o   Zimmermann, M ^o   Ellenberg, A ^o   Minagar, A ^o   Kelley, R ^o   McGee, J ^o   Jinkins, P ^o   Bezucha, S ^o   Hart, V ^o   Bonora, M ^o   Sawyer, R ^o   Ammerman, K ^o   Ramappa, P ^o   Berchou, V ^o   Jones, E ^o   Olgren, E ^o   Hattler, B ^o   Anderson, C ^o   Watson, B ^o   Wolf, D ^o   Kosits, J ^o   Palmeri, S ^o   Casazza, L ^o   Yip, D ^o   Meschia, J ^o   McPhail, A ^o   Greenan, K ^o   Rothbart, R ^o   Love, J ^o   Schrader, T ^o   Garman, V ^o   Stoddard, M ^o   Remmel, K ^o   Longaker, R ^o   Gerula, C ^o   Klapholz, M ^o   Kirmani, J ^o   Mattessich, R ^o   Rodriguez, C ^o   Graettinger, W ^o   Baker, A ^o   Kosolcharoen, P ^o   Williams, L ^o   Sorrell, V ^o   Coull, B ^o   Bruck, D ^o   Ofili, E ^o   Frankel, M ^o   Jackson, P ^o   Nanna, M ^o   Yasen, J ^o   Sparr, S ^o   Almeida, W ^o   Libman, R ^o   Stephens, B ^o   DeMers, C ^o   Giles, T ^o   Roffidal, L ^o   Barratt, D ^o   Liston, M ^o   Lindsey, C ^o   Giron, L ^o   Felton, W ^o   Joseph, L ^o   Lee, M ^o   Bisognano, J ^o   Benesch, C ^o   Caufield, L ^o   Nishime, E ^o   Moussavian, M ^o   Polland, E ^o   Fischer, L ^o   Peterson, K ^o   McGinnis, B ^o   Tilem, M ^o   Allam, G ^o   Beebe, J ^o   Chang, P ^o   Sen, S ^o   Schuler, C ^o   Arcement, L ^o   Charlet, M ^o   Falgout, E ^o   Malkowski, M ^o   Dugan, T ^o   Hobbs Williams, J ^o   Warner, A ^o   Panizzon, K ^o   Johnson, J ^o   Dissin, J ^o   Karia, D ^o   Molakala, N ^o   Dandapani, B ^o   Vicari, R ^o   Anthony, E ^o   Katzan, I ^o   Hobbs, R ^o   Richmond, A ^o   Hughes, R ^o   Baker, W ^o   Applegate, M ^o   Drachman, B ^o   Khella, S ^o   Donovan, S ^o   Slim, A ^o   Darrow, B ^o   Travis, A ^o   Mercando, A ^o   Pellegrino, R ^o   Jarmukli, N ^o   Ochalek, T ^o   Janosik, D ^o   Dizes, J ^o   Pettigrew, L C ^o   Taylor, D ^o   Hanna, J ^o   Bailey, S ^o   Berkowitz, R ^o   Mathus, S ^o   Virkud, V ^o   Shaw, S ^o   Nabhan, S ^o   Wirkowski, E ^o   George, B ^o   Smith, E ^o   Locke, S ^o   Landau, C ^o   Ferguson, D ^o   Anderson, H V ^o   Westbrook, L ^o   Apelian, M ^o   Khoury, S ^o   Leppo, J ^o   Bator, T ^o   Thadani, U ^o   Turner, J ^o   Goldman, S ^o   Daugherty, S ^o   Adler, A ^o   Rennie, T ^o   Chupka, D ^o   Katz, R ^o   Witkin, L ^o   Burgin, W ^o   Weber, C ^o   Boehmer, J ^o   Frey, P ^o   Wilson, M ^o   Tworek, H ^o   Mallis, G ^o   Mauceri, D ^o   Schneider, R ^o   Schneider, W ^o   Ortiz, G ^o   Lichtenberger, M ^o   Hott, B ^o   Patrick, D ^o   Dunlap, S ^o   Kim, S J ^o   Pezzella, S ^o   Aubin, D ^o   Nikolaidis, L ^o   Wong, J ^o   Leifer, D ^o   Rossi, M ^o   Torre, G ^o   Arredondo, J ^o   Lynch, J ^o   Metcalf, A ^o   Gonzalez, J ^o   Donley, B ^o   Cappola, T ^o   Craig, K ^o   Bozkurt, B ^o   Bolos, M ^o   Noonan, T ^o   Alteri, C ^o   Kowalczyk, L ^o   Cwynar, A ^o   Drazek, D ^o   Biegus, J ^o   Szelemej, R ^o   Jurczok, M ^o   Serafin, R ^o   Jurczyk, A ^o   Ogorek, M ^o   Kopcik, D ^o   Metzkier Wyrwa, B ^o   Szczepanska, A ^o   Dluzniewski, M ^o   Modzelewski, M ^o   Wicha, W ^o   Kuch, M ^o   Kuc, K ^o   Piotrowski, R ^o   Lesniak, O ^o   Krauze Wielicka, M ^o   Herman, J ^o   Nowakowska, S ^o   Pasierski, T ^o   Kozlowski, B ^o   Wolkowska, K ^o   Juszczak, A ^o   Michalska, J ^o   Jedlinski, I ^o   Miekus, P ^o   Konarzewski, M ^o   Berkowski, P ^o   Jacek, N ^o   Kalarus, Z ^o   Duszanska, A ^o   Tarchalski, J ^o   Czaja, P ^o   Gaciong, Z ^o   Gora, J ^o   Kleinrok, A ^o   Prokop Lewicka, G ^o   Haddad, H ^o   Davies, R ^o   Sitwell, L ^o   Donaldson, J ^o   Yufe, R ^o   Donelly, B ^o   Huynh, T ^o   Cote, R ^o   Jacques, B ^o   Borts, D ^o   Tullio, G ^o   Sindilar, A M ^o   Winder, T ^o   Janzen, E ^o   Walker, C ^o   Moe, G ^o   Bayer, N ^o   Konig, A ^o   Arnold, M ^o   Spence, D ^o   Smith, J ^o   Bessoudo, R ^o   Bailey, P ^o   McNulty, A ^o   Nawaz, S ^o   Dewar, C ^o   Minuk, J ^o   Schanz, C ^o   Penn, A ^o   Atkins, L ^o   Ducharme, A ^o   Brown, H ^o   Zieroth, S ^o   Munoz A ^o   van Bujisen Nutters, A ^o   Daniels, M ^o   Coppes, A ^o   van Zagten, M ^o   Elzebroek, N ^o   Hamroui, K ^o   de Kort, P ^o   Vuijsters, J ^o   Ziekenhuis, E ^o   Holwerda, N ^o   Hermans, W ^o   van der Loo, R ^o   Wajon, E ^o   Hageman, G ^o   Buchem Damming, G ^o   de Graaf Gasthuis, R ^o   Ronner, E ^o   van Hessen, A ^o   Verheul, G A ^o   Linssen, G ^o   Pas, L ^o   Plomp, J ^o   de Milliano, P A ^o   Breedveld, R ^o   Bos, M J ^o   Houra, M ^o   Beran, D ^o   Lebedova, R ^o   Carda, J ^o   Bednarova, E ^o   Vosmerova, J ^o   Marcinek, G ^o   Drasnar, T ^o   Najmanova, O ^o   Dunaj, M ^o   Pechackova, E ^o   Kuchar, M ^o   Jansky, P ^o   Simon, J ^o   Dvorakova, H ^o   Gregor, P ^o   Maruskova, M ^o   Svoboda, L ^o   Lorenc, Z ^o   Kralicek, P ^o   Pollak, L ^o   Krobot, M ^o   Spinar, J ^o   Nemec, M ^o   Spinarova, L ^o   Kuba, R ^o   Padour, F ^o   Padourova, I ^o   Padour, M ^o   Michalova, M ^o   Golan, L ^o   Hajkova, M ^o   Povolny, J ^o   Krizova, L ^o   Horak, D ^o   Kucera, P ^o   Malek, I ^o   Krizova, B ^o   Svoboda, J ^o   Ferkl, R ^o   Regos, L ^o   Csuros, L ^o   Lovasz, O ^o   Kiss, G ^o   Timar, S ^o   Torok, N ^o   Hajnalne, A ^o   Palossy, B ^o   Nagy, A ^o   Fulop, P ^o   Jakab, G ^o   Ronaszeki, A ^o   Bodi, M ^o   Satori, M ^o   Edes, I ^o   Varga, I ^o   Kovacs, A ^o   Berente, L ^o   Peterfai E ^o   Pauer, R ^o   Toth, K ^o   Nagy, E ^o   Benczur, B ^o   Karsay, K ^o   Vegh, T ^o   Nagy, R ^o   Karpati, P ^o   Davidovits, Z ^o   Borbola, J ^o   Vanyi, J ^o   Oze, B ^o   Bujdoso, A ^o   Kosa, I ^o   Baliko, L ^o   Natour, M ^o   Morgil, M ^o   Hartmann, E ^o   Morgil, H ^o   Winkler, R ^o   Gass, S ^o   Baumann, S ^o   Jeserich, M ^o   Rodl, J ^o   Dzaiy, M ^o   Turhan, G ^o   Wolf, K ^o   Genth Zotz, S ^o   Siebert, T ^o   Jakobs, C ^o   Kiorwantsi, M ^o   Pieske, B ^o   Wachter, R ^o   Schoenauer, M ^o   Voigt, S ^o   Schunkert, H ^o   Boguschewski, A ^o   Resch, M ^o   Wensel, R ^o   Schumann, V ^o   Heidrich, P ^o   Girina, O ^o   Prokopovych, Y ^o   Lebedynska, M ^o   Sorokina, I ^o   Karpenko, O ^o   Brodi, N ^o   Klochkov, S ^o   Voronkov, L ^o   Besaga, Y ^o   Novikova, O ^o   Amosova, K ^o   Yaremenko, O ^o   Balaban, K ^o   Kovalenko, V ^o   Polenova, N ^o   Sakharchuk, I ^o   Ogorodnichuk, A ^o   Rudenko, L ^o   Tutov, Y ^o   Parkhomenko, A ^o   Kozhukhov, S ^o   Yakimenko, E ^o   Kolomiets, S ^o   Yurlov, V ^o   Tikhonova, S ^o   Elizalde, A ^o   Mangariello, B ^o   Zaidman, C ^o   Guerlloy, F ^o   Gitelman, P ^o   Crotto, K ^o   Sassone, S ^o   Aiub, J ^o   Novoa, F ^o   Santi, R ^o   Romia, P ^o   Montana O ^o   Malchik, D ^o   Sokn, F ^o   Schygiel, P ^o   Porcile, R ^o   Tito, F ^o   Thierer, J ^o   Avellana, P ^o   Rapallo, C ^o   Calderon, M ^o   MacFadyen, R ^o   Haynes, R ^o   Partridge, J ^o   Kokles, M ^o   Mehesova S ^o   Zachar, A ^o   Hranai, M ^o   Varadyova, T ^o   Litvinova, J ^o   Loviska, P ^o   more..

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d WASHINGTON UNIVERSITY   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENT   (United Kingdom)

^g LEHIGH VALLEY HOSPITAL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ State University of New York Upstate Medical University: College of Medicine   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k Centro Neurol de Tratamiento/Rehab   (Argentina)

^l DEVENTER HOSPITAL   (Netherlands)

^m WROCLAW MEDICAL UNIVERSITY   (Poland)

ⁿ UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^o NONE

more..

Author keywords

anticoagulant; heart failure; hemorrhage; stroke

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; ANTICOAGULATION; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; TREATMENT DURATION; TREATMENT OUTCOME; AGED; CEREBRAL HEMORRHAGE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DOUBLE BLIND PROCEDURE; DRUG MONITORING; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK FACTOR; STROKE; TIME;

AGED; ANTICOAGULANTS; ASPIRIN; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; HEART FAILURE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; WARFARIN;

EID: 84942937011     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001725     Document Type: Article

References (23)

1. Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes. 2008;1:84-91. doi: 10.1161/CIRCOUTCOMES.108.796185.
2. Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. 2011;106:968-977. doi: 10.1160/TH11-05-0353.
3. Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM. Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. Thromb Res. 2009;124:37-41. doi: 10.1016/j.thromres.2008.09.016.
4. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S; ACTIVE W Investigators. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation. 2008;118:2029-2037. doi: 10.1161/CIRCULATIONAHA.107.750000.
5. White HD, Gruber M, Feyzi J, Kaatz S, Tse HF, Husted S, Albers GW. Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V. Arch Intern Med. 2007;167:239-245. doi: 10.1001/archinte.167.3.239.
6. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI; European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease. Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost. 2013;109:769-786. doi: 10.1160/TH12-06-0403.
7. Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366:1859-1869. doi: 10.1056/NEJMoa1202299.
8. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69:236-239.
9. Lee DS, Gona P, Albano I, Larson MG, Benjamin EJ, Levy D, Kannel WB, Vasan RS. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ Heart Fail. 2011;4:36-43. doi: 10.1161/CIRCHEARTFAILURE.110.957480.
10. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Packer M, Poole-Wilson PA, Ryden L. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. Circulation. 2000;102:611-616.
11. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-2925. doi: 10.1161/01.CIR.0000072767.89944.6E.
12. Tayal AH, Tian M, Kelly KM, Jones SC, Wright DG, Singh D, Jarouse J, Brillman J, Murali S, Gupta R. Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or stroke. Neurology. 2008;71:1696-1701. doi: 10.1212/01.wnl.0000325059.86313.31.
13. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478-2486. doi: 10.1056/NEJMoa1313600.
14. Gallagher AM, Rietbrock S, Plumb J, van Staa TP. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis J Thromb Haemost. 2008;6:1500-1506. doi: 10.1111/j.1538-7836.2008.03059.x.
15. Ferreira J, Ezekowitz MD, Connolly SJ, Brueckmann M, Fraessdorf M, Reilly PA, Yusuf S, Wallentin L; RE-LY Investigators. Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial. Eur J Heart Fail. 2013;15:1053-1061. doi: 10.1093/eurjhf/hft111.
16. van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Nessel CC, Singer DE, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW. Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF. Circ Heart Fail. 2013;6:740-747. doi: 10.1161/CIRCHEARTFAILURE.113.000212.
17. McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ Heart Fail. 2013;6:451-460. doi: 10.1161/CIRCHEARTFAILURE.112.000143.
18. Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study. Thromb Haemost. 2012;107:584-589. doi: 10.1160/TH11-11-0784.
19. Pisters R, Nieuwlaat R, Lane DA, Crijns HJ, Lip GY. Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation. A modelling analysis from the Euro Heart Survey. Thromb Haemost. 2013;109:328-336. doi: 10.1160/TH12-08-0539.
20. van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest. 2006;129:1155-1166. doi: 10.1378/chest.129.5.1155.
21. Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G, Halperin JL, Becker RC, Breithardt G, Hankey GJ, Hacke W, Nessel CC, Patel MR, Califf RM, Fox KA; ROCKET AF Investigators. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial. J Am Heart Assoc. 2013;2:e000067. doi: 10.1161/JAHA.112.000067.
22. Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013;127:2166-2176. doi: 10.1161/CIRCULATIONAHA.112.142158.
23. Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ; RE-LY Investigators. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010;376:975-983. doi: 10.1016/S0140-6736(10)61194-4.